An Exploratory Study on the Efficacy and Safety of Enlonstobart Combined With Concurrent Radiotherapy and Chemotherapy Following Induction Therapy With Enlonstobart Plus Chemotherapy in Patients With Locally Advanced Cervical Cancer.
Clinical trial NCT07776821 · RECRUITING
Trial details
- NCT number
- NCT07776821
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2026-11-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.